Stock GEAN GENETIC ANALYSIS
Add to a list
To use this feature you must be a member
Log inSign up

News Genetic Analysis

Equities

GEAN

NO0010692130

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 18:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
0.61 NOK +5.90% Intraday chart for Genetic Analysis -2.24% -28.24%
02-29 Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
02-26 Genetic Analysis AS Announces CE-IVD Marking for its GA-map Sample Collection Kit CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Genetic Analysis AS: Notice of Annual General Meeting 2024
AQ
Genetic Analysis AS: Mandatory notification of trade - Primary Insider
AQ
Genetic Analysis AS: Publication of Annual Report 2023
AQ
Genetic Analysis AS: Mandatory notification of trade - Primary Insider
AQ
Year-end report January - December 2023
AQ
Genetic Analysis AS Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Genetic Analysis AS: Genetic Analysis AS announces CE-IVDR marking for its GA-map® Sample Collection Kit
AQ
Genetic Analysis AS Announces CE-IVD Marking for its GA-map Sample Collection Kit
CI
Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises
AQ
Genetic Analysis announces final outcome of the subsequent offering to existing shareholders
AQ
Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders
AQ
Genetic Analysis partners up to enter the consumer market with GA-map®
AQ
Genetic Analysis Partners Up to Enter the Consumer Market with Ga-Map
CI
Genetic Analysis summarizes this year's product development activities and looks ahead to 2024
AQ
Today, the subscription period in Genetic Analysis subsequent offering begins
AQ
Genetic Analysis publishes information memorandum relating to the previously announced subsequent offering
AQ
Genetic Analysis announces final number of subscription rights received per existing share in the previously announced subsequent offering
AQ
Genetic Analysis announces terms of the previously announced subsequent offering to shareholders of up to appr. NOK 9 million
AQ
Genetic Analysis AS: Mandatory notification of trade
AQ
Genetic Analysis AS: Minutes from the Extraordinary General Meeting
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GEAN Stock
  4. News Genetic Analysis